Corrigendum to 'Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease' EBioMedicine 47 (2019) 446-456.
EBioMedicine
; 52: 102595, 2020 Feb.
Article
in En
| MEDLINE
| ID: mdl-31982828
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
EBioMedicine
Year:
2020
Document type:
Article
Country of publication: